Agilent (A) reported earnings 30 days ago. What's next for the stock?
Agilent Technologies, Inc. (NYSE:A ) Jefferies Global Healthcare Conference Call June 4, 2025 10:30 AM ET Company Participants Padraig McDonnell - CEO, President & Director Robert W. McMahon - Senior VP & CFO Conference Call Participants Tycho W.
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
![]() A In 3 days Announced | Quarterly | $0.25 Per Share |
![]() A 2 months ago Paid | Quarterly | $0.25 Per Share |
![]() A 5 months ago Paid | Quarterly | $0.25 Per Share |
![]() A 8 months ago Paid | Quarterly | $0.24 Per Share |
![]() A 11 months ago Paid | Quarterly | $0.24 Per Share |
19 Aug 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
28 May 2025 Date | | 1.26 Cons. EPS | 1.31 EPS |
25 Feb 2025 Date | | 1.27 Cons. EPS | 1.31 EPS |
25 Nov 2024 Date | | 1.41 Cons. EPS | 1.46 EPS |
18 Nov 2024 Date | | 1.41 Cons. EPS | - EPS |
![]() A In 3 days Announced | Quarterly | $0.25 Per Share |
![]() A 2 months ago Paid | Quarterly | $0.25 Per Share |
![]() A 5 months ago Paid | Quarterly | $0.25 Per Share |
![]() A 8 months ago Paid | Quarterly | $0.24 Per Share |
![]() A 11 months ago Paid | Quarterly | $0.24 Per Share |
19 Aug 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
28 May 2025 Date | | 1.26 Cons. EPS | 1.31 EPS |
25 Feb 2025 Date | | 1.27 Cons. EPS | 1.31 EPS |
25 Nov 2024 Date | | 1.41 Cons. EPS | 1.46 EPS |
18 Nov 2024 Date | | 1.41 Cons. EPS | - EPS |
Medical - Diagnostics & Research Industry | Healthcare Sector | Padraig McDonnell CEO | XHAN Exchange | US00846U1016 ISIN |
US Country | 17,900 Employees | 1 Jul 2025 Last Dividend | 3 Nov 2014 Last Split | - IPO Date |
Agilent Technologies, Inc. stands as a global provider offering application-focused solutions primarily to the life sciences, diagnostics, and applied chemical sectors. The company propagates its mission across three distinct segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab, ensuring a broad spectrum of scientific research, diagnostic, and analytical needs are met worldwide. Since its establishment in 1999, Agilent has cemented its headquarters in Santa Clara, California, from where it orchestrates its global operations, offering an expansive portfolio through direct sales, distributors, resellers, and electronic commerce frameworks.